BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15772224)

  • 1. The natural history of left ventricular systolic function in Anderson-Fabry disease.
    Shah JS; Lee P; Hughes D; Thaman R; Sachdev B; Pellerin D; Mehta A; Elliott PM
    Heart; 2005 Apr; 91(4):533-4. PubMed ID: 15772224
    [No Abstract]   [Full Text] [Related]  

  • 2. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.
    Takenaka T; Teraguchi H; Yoshida A; Taguchi S; Ninomiya K; Umekita Y; Yoshida H; Horinouchi M; Tabata K; Yonezawa S; Yoshimitsu M; Higuchi K; Nakao S; Anan R; Minagoe S; Tei C
    J Cardiol; 2008 Feb; 51(1):50-9. PubMed ID: 18522775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
    Hughes DA; Elliott PM; Shah J; Zuckerman J; Coghlan G; Brookes J; Mehta AB
    Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction.
    Goldberg LR; Jessup M
    Circulation; 2006 Jun; 113(24):2851-60. PubMed ID: 16785351
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe left ventricular hypertrophy in Anderson-Fabry disease.
    Bhatia GS; Leahy JF; Connolly DL; Davis RC
    Heart; 2004 Oct; 90(10):1136. PubMed ID: 15367506
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment.
    Weidemann F; Niemann M; Breunig F; Herrmann S; Beer M; Störk S; Voelker W; Ertl G; Wanner C; Strotmann J
    Circulation; 2009 Feb; 119(4):524-9. PubMed ID: 19153271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease.
    Shah JS; Hughes DA; Sachdev B; Tome M; Ward D; Lee P; Mehta AB; Elliott PM
    Am J Cardiol; 2005 Sep; 96(6):842-6. PubMed ID: 16169374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular tachycardias and dilated cardiomyopathy caused by Fabry disease.
    Igawa O; Miake J; Hisatome I
    Pacing Clin Electrophysiol; 2005 Oct; 28(10):1142-3. PubMed ID: 16221278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aortic valve replacement: a safe and durable option in patients with impaired left ventricular systolic function.
    Chukwuemeka A; Rao V; Armstrong S; Ivanov J; David T
    Eur J Cardiothorac Surg; 2006 Feb; 29(2):133-8. PubMed ID: 16386914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of cardiovascular magnetic resonance in the diagnosis of Anderson-Fabry disease.
    Gange CA; Link MS; Maron MS
    Circulation; 2009 Sep; 120(13):e96-7. PubMed ID: 19786638
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of heart failure and left ventricular systolic dysfunction after cardiac pacing in patients with preserved left ventricular systolic function.
    Kachboura S; Ben Halima A; Fersi I; Marrakchi S; Zouaoui W; Kammoun I
    Ann Cardiol Angeiol (Paris); 2008 Feb; 57(1):29-36. PubMed ID: 18062936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromes.
    Bennett KM; Hernandez AF; Chen AY; Mulgund J; Newby LK; Rumsfeld JS; Hochman JS; Hoekstra JW; Ohman EM; Gibler WB; Roe MT; Peterson ED
    Am J Cardiol; 2007 May; 99(10):1351-6. PubMed ID: 17493458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of chronic obstructive pulmonary disease with pulmonary hypertension on both left ventricular systolic and diastolic performance.
    Yilmaz R; Gencer M; Ceylan E; Demirbag R
    J Am Soc Echocardiogr; 2005 Aug; 18(8):873-81. PubMed ID: 16084341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy.
    Ortiz A; Oliveira JP; Waldek S; Warnock DG; Cianciaruso B; Wanner C;
    Nephrol Dial Transplant; 2008 May; 23(5):1600-7. PubMed ID: 18175781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered myocardial motion pattern in Fabry patients assessed with CMR-tagging.
    Rutz AK; Juli CF; Ryf S; Widmer U; Kozerke S; Eckhardt BP; Boesiger P
    J Cardiovasc Magn Reson; 2007; 9(6):891-8. PubMed ID: 18066749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular dysfunction in atrial fibrillation: restoration of sinus rhythm by the Cox-maze procedure significantly improves systolic function and functional status.
    Stulak JM; Dearani JA; Daly RC; Zehr KJ; Sundt TM; Schaff HV
    Ann Thorac Surg; 2006 Aug; 82(2):494-500; discussion 500-1. PubMed ID: 16863752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.
    Hoigné P; Attenhofer Jost CH; Duru F; Oechslin EN; Seifert B; Widmer U; Frischknecht B; Jenni R
    Int J Cardiol; 2006 Aug; 111(3):413-22. PubMed ID: 16307805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
    Amigoni M; Meris A; Thune JJ; Mangalat D; Skali H; Bourgoun M; Warnica JW; Barvik S; Arnold JM; Velazquez EJ; Van de Werf F; Ghali J; McMurray JJ; Køber L; Pfeffer MA; Solomon SD
    Eur Heart J; 2007 Feb; 28(3):326-33. PubMed ID: 17251259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal profile and fertility in patients with Anderson-Fabry disease.
    Hauser AC; Gessl A; Harm F; Wiesholzer M; Kleinert J; Wallner M; Voigtländer T; Bieglmayer C; Sunder-Plassmann G
    Int J Clin Pract; 2005 Sep; 59(9):1025-8. PubMed ID: 16115176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.